To test this possibility, we compared the half-life of HSP90AA1 in HCC cells with or without FBXL6 expression and found that the half-life of HSP90AA1 in FBXL6 KO cells was significantly reduced relative to the WT counterpart (Fig. 4f). This evidence concerns the gene HSP90AA1 and hepatocellular carcinoma.